CDC Enterprises
VC Fund
Paris, France
CDC Enterprises is a French Government (French treasury) owned €150 million fund of funds, that encourages more early-stage co-funds. Very little information can be found on the internet for this financial organization. If you have more information, please update this profile.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries CDC Enterprises invests in
Stages CDC Enterprises invests in
Countries CDC Enterprises invests in
Round sizes
Round size
- Series B
- $11M–$33M
- Series C
- $5.4M–$8.8M
Investment Focus
Industry
- Electronics 4 (31%)
- Manufacturing 4 (31%)
- Software 2 (15%)
- Consulting 2 (15%)
- Health Care 2 (15%)
Stage
- Series B 4 (31%)
- Series C 2 (15%)
- Funding Round 2 (15%)
- Seed 1 (8%)
- Series A 1 (8%)
Country
- France 9 (69%)
- Germany 1 (8%)
- United States 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
KIPLIN
|
Games to prevent sedentary lifestyle and to help you walk and move daily | $3.2M / Seed / Sep 21, 2021 | |
SuperSonic Imagine
|
SuperSonic Imagine SA develops and manufactures ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company provides Aixplorer, an ultrasound system for breast lesion imaging; and ShearWave, an ultrasound technology platform for quantitative elastography. It offers its products through its offices and a networkof distributors in France, Belgium, Austria, Croatia, Poland, the Czech Republic, Singapore, Taiwan, Thailand, Malaysia, Hong Kong, Lebanon, Germany, the United Kingdom, and the United States. SuperSonic Imagine SA was founded in 2005 and is based in Aix-en-Provence, France with additional offices in Germany, the United States, and the United Kingdom. | $30.7M / Private Equity / Apr 02, 2013 | |
McPhy
|
McPhy Energy is a french cleantech company which develops solid state hydrogen storage technology. | $11M / Jan 17, 2013 | |
Delfmems
|
Delfmems SAS develops, manufactures, and licenses radio-frequency micro-electro-mechanical-systems switching technology for small-signal switching applications. It offers stand-alone single pole double throw radio frequency switches for automatic test equipment and instrumentation, mobile, telecom infrastructure, military, and space applications.The company's technology also allows developing digital and variable capacitors. Delfmems SAS was founded in 2005 and is headquartered in Villeneuve d'Ascq, France. | $10.5M / Series B / Jan 15, 2013 | |
Amplitude
|
AMPLITUDE TECHNOLOGIES is the global expert in the science, design and manufacture of high performance laser systems for a variety of specialist applications.ln addition to systems used for fundamental physics research, the company is a leading authority in the medical research domain including radiography and cancer treatment projects.AMPLITUDE TECHNOLOGIES offers worldwide project management experience. Its comprehensive project management program provides industry-leading levels of customer support.From the first steps of the design concept, to laboratory installation, training and ongoing after-sales requirements, the Amplitude team is on-hand to provide the support the application demands.Over a decade' s experience in the Science, design and development, and support of state-of-the-art systems in the field means that every AMPLITUDE TECHNOLOGIES system is engineered to be extremely robust and reliable, offering unparalleled performance no matter what the application. | $32.9M / Series B / Jan 25, 2012 | |
Nexway
|
Founded in 1995, Nexway exists to expand the online footprint and sales potential of software, retail, and services companies across 140 countries around the world.Nexway blends cutting-edge technology, a full range of industry-leading ecommerce and payment solutions, and a hands-on team of industry experts to help online businesses scale, grow,and thrive in today’s global sales marketplace.Their customers rely on Nexway to power their subscription models, manage local payment methods, prevent fraud, engage partners and resellers, deliver key customer insights, and beyond. Not only do they help grow their online businesses globally but they also create a frictionless customer experience that drives unparalleled conversion, retention, and loyalty.Their software distribution origins run deep. From the very beginning, they have operated Nexway Connect, a global video game and software distribution network for leading media companies and online merchants. With asknet academics, they now also serve as a single sourcing point for software e-procurement solutions and services for academic institutions worldwide. | $15.4M / Series B / Jul 07, 2010 | |
Crocus Technology
|
Crocus Technology SA provides magnetic random access memory products and technologies for the semiconductor and electronic systems industries. It offers its products for use in telecommunication, networking, storage, computing, and handheld applications. | $8.8M / Series C / May 03, 2010 | |
Alyotech
|
Alyotech Group is an international industrial holding company which aims to consolidate and unite, by strategy build-up companies specializing in the field of technology consulting.A policy of external growth, representing two thirds of overall growth, has been established within the Group Alyotech. By late 2008, the group should achieve aturnover of 150 million and be listed. | $4.4M / Jul 11, 2008 | |
|
Alyotech
|
Alyotech Group is an international industrial holding company which aims to consolidate and unite, by strategy build-up companies specializing in the field of technology consulting.A policy of external growth, representing two thirds of overall growth, has been established within the Group Alyotech. By late 2008, the group should achieve aturnover of 150 million and be listed. | $11M / Jun 26, 2007 | |
Cytheris
|
Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation. These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such aschemotherapy, radiotherapy, bone marrow transplantation (BMT) and hematopoietic cell transplantation (HCT). | $30.7M / Series B / Oct 25, 2006 | |
| See all 13 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does CDC Enterprises invest in?
CDC Enterprises invests primarily in Electronics, Manufacturing and Software startups, most often at Series B and Series C stage. Most of the 13 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is CDC Enterprises's check size?
CDC Enterprises typically joins rounds of $11M–$33M at Series B and $5.4M–$8.8M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds CDC Enterprises participates in.
When did CDC Enterprises last invest?
The most recent investment recorded for CDC Enterprises closed in Sep 2021. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
